Moderna vaccine is proved ‘protective’ against Covid-19 variants

FILE PHOTO

As fear over new variants of Covid-19 had prompted the travel restrictions to tighten worldwide, the United States biotech firm Moderna announced that its vaccine should protect against the variants identified in the United Kingdom and South Africa.

Latest studies on the efficacy of Moderna vaccines confirmed that the vaccines are effective and protective against new variants. The company will continue more tests adding a second booster of its vaccine, bringing to 3 shots in a total.

“We are encouraged by these new data, which reinforce our confidence that the Moderna Covid-19 vaccine should be protective against these newly detected variants.”

Last month, a private hospital in Bangkok advertised pre-orders for the Moderna vaccine, which still needs approval from Thailand’s FDA. Thailand’s Department of Health Service Support demanded that the hospital remove the advertisements.

In the ads, the hospital was charging 4,000 baht for a booking of the vaccine. In the post the hospital said the vaccine would arrive in Thailand in October 2021. They also announced that the vaccine would cost 6,000-10,000 baht.

Health officials say private hospitals will be allowed to administer vaccines that are approved by the FDA. So far, the Thai government has only approved the AstraZeneca vaccine for emergency use. The first batch of 50,000 doses are expected to arrive next month. Frontline health care workers and vulnerable groups in high risk areas will be first to receive the vaccine.

SOURCE: Bangkok Post

Covid-19 NewsWorld News

Thaiger Talk

Join the conversation and have your say on Thailand news published on The Thaiger.

Thaiger Talk is our new Thaiger Community where you can join the discussion on everything happening in Thailand right now.

Please note that articles are not posted to the forum instantly and can take up to 20 min before being visible. Click for more information and the Thaiger Talk Guidelines.

4 Comments

Leave a Reply

Related Articles

Leave a Reply